Related Experiment Video
Updated: Jun 14, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
Published on: May 10, 2016
[Toxicological characteristics of cumazid]
Abstract:
Cumazid, a new prophylactic immunotherapy preparation, has been created based on the total glycoside fraction isolated from Cucumaria japonica sea cucumber species. The acute and chronic toxicity of the preparation has been characterized according to the pharmacopoeieal requirements. With respect to the acute toxicity upon intragastric administration, cumazid belongs to class IV (weakly dangerous) drugs. In 3-month chronic tests, cumazid administered in doses within 1 - 100 microg/kg did not produce any significant toxic action on laboratory animals.
Related Concept Videos
Physical Properties of Amines
Toxicity Testing in Animals
Drug Toxicity: Overview
Drug Toxicity: Risk factors
Toxicokinetics: Overview
Drug Toxicity: Dose-Dependent Reactions
